Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Walters

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of the National Comprehensive Cancer Network : JNCCN|May 13, 2018
Redefining Quality Measurement in Cancer CareElizabeth A Nardi, James McCanney, Katy Winckworth-Prejsnar, et al.
Annals of Surgery|December 19, 2019
National Quality Forum Guidelines for Evaluating the Scientific Acceptability of Risk-adjusted Clinical Outcome Measures: A Report From the National Quality Forum Scientific Methods PanelLaurent G Glance, Karen Joynt Maddox, Karen Johnson, et al.
Clinical Breast Cancer|December 17, 2008
Using response to primary chemotherapy to select postoperative therapy: long-term results from a prospective phase II trial in locally advanced primary breast cancerAna Maria Gonzalez-Angulo, Ronald Walters, Kristine Broglio, et al.
International Journal of Particle Therapy|November 28, 2019
Variations in Proton Therapy Coverage in the State of Texas: Defining Medical Necessity for a Safe and Effective TreatmentNikhil G Thaker, Ankit Agarwal, Matthew Palmer, et al.
Cancer Chemotherapy and Pharmacology|September 30, 2006
Phase II trial of 10-EDAM in the treatment of metastatic breast cancerGarth A Beinart, Ana M Gonzalez-Angulo, Kristine Broglio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2004
The use of alternate, non-cross-resistant adjuvant chemotherapy on the basis of pathologic response to a neoadjuvant doxorubicin-based regimen in women with operable breast cancer: long-term results from a prospective randomized trialEva Thomas, Frankie A Holmes, Terry L Smith, et al.
The Oncologist|November 2, 2011
Phase III randomized trial of dose intensive neoadjuvant chemotherapy with or without G-CSF in locally advanced breast cancer: long-term resultsBanu K Arun, Kapil Dhinghra, Vicente Valero, et al.
Annals of Surgical Oncology|March 17, 2016
Value-Based Breast Cancer Care: A Multidisciplinary Approach for Defining Patient-Centered OutcomesOluwadamilola M Fayanju, Tinisha L Mayo, Tracy E Spinks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
Evaluation of paclitaxel in adjuvant chemotherapy for patients with operable breast cancer: preliminary data of a prospective randomized trialAman U Buzdar, S Eva Singletary, Vicente Valero, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of the National Comprehensive Cancer Network : JNCCN|May 13, 2018
Redefining Quality Measurement in Cancer CareElizabeth A Nardi, James McCanney, Katy Winckworth-Prejsnar, et al.
Annals of Surgery|December 19, 2019
National Quality Forum Guidelines for Evaluating the Scientific Acceptability of Risk-adjusted Clinical Outcome Measures: A Report From the National Quality Forum Scientific Methods PanelLaurent G Glance, Karen Joynt Maddox, Karen Johnson, et al.
Clinical Breast Cancer|December 17, 2008
Using response to primary chemotherapy to select postoperative therapy: long-term results from a prospective phase II trial in locally advanced primary breast cancerAna Maria Gonzalez-Angulo, Ronald Walters, Kristine Broglio, et al.
International Journal of Particle Therapy|November 28, 2019
Variations in Proton Therapy Coverage in the State of Texas: Defining Medical Necessity for a Safe and Effective TreatmentNikhil G Thaker, Ankit Agarwal, Matthew Palmer, et al.
Cancer Chemotherapy and Pharmacology|September 30, 2006
Phase II trial of 10-EDAM in the treatment of metastatic breast cancerGarth A Beinart, Ana M Gonzalez-Angulo, Kristine Broglio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2004
The use of alternate, non-cross-resistant adjuvant chemotherapy on the basis of pathologic response to a neoadjuvant doxorubicin-based regimen in women with operable breast cancer: long-term results from a prospective randomized trialEva Thomas, Frankie A Holmes, Terry L Smith, et al.
The Oncologist|November 2, 2011
Phase III randomized trial of dose intensive neoadjuvant chemotherapy with or without G-CSF in locally advanced breast cancer: long-term resultsBanu K Arun, Kapil Dhinghra, Vicente Valero, et al.
Annals of Surgical Oncology|March 17, 2016
Value-Based Breast Cancer Care: A Multidisciplinary Approach for Defining Patient-Centered OutcomesOluwadamilola M Fayanju, Tinisha L Mayo, Tracy E Spinks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
Evaluation of paclitaxel in adjuvant chemotherapy for patients with operable breast cancer: preliminary data of a prospective randomized trialAman U Buzdar, S Eva Singletary, Vicente Valero, et al.
Pageof 2